Literature DB >> 475368

In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.

T F Smith.   

Abstract

Thirty-two clinical isolates of Ureaplasma urealyticum were inhibited by 0.036 mug of rosaramicin per ml, whereas 25 (78%) and 13 (41%) of the strains were inhibited by this concentration of minocycline and tetracycline, respectively. These results suggest that rosaramicin may be useful for the treatment of U. urealyticum infections.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 475368      PMCID： PMC352799          DOI： 10.1128/AAC.16.1.106

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Research for new antibiotics in the treatment of gonorrhea and nonspecific urethritis.

Authors:  B B Diena; L Eidus
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

2.  Human intra-urethral inoculation of ureplasmas.

Authors:  D Taylor-Robinson; G W Csonka; M J Prentice
Journal:  Q J Med       Date:  1977-07

3.  Etiology and treatment of nongonococcal urethritis.

Authors:  W R Bowie
Journal:  Sex Transm Dis       Date:  1978 Jan-Mar       Impact factor: 2.830

4.  In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.

Authors:  T F Smith; H E Washton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Serological typing of Ureaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method.

Authors:  M C Shepard; C D Lunceford
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

6.  In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.

Authors:  J Santoro; D Kaye; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

7.  In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

8.  Simple, direct broth-disk method for antibiotic susceptibility testing of Ureaplasma urealyticum.

Authors:  M S Spaepen; R B Kundsin
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

9.  Differential response of chlamydial and ureaplasma-associated urethritis to sulphafurazole (sulfisoxazole) and aminocyclitols.

Authors:  W R Bowie; J F Floyd; Y Miller; E R Alexander; J Holmes; K K Holmes
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

10.  Differences in the growth requirements of some strains of Ureaplasma urealyticum of human origin.

Authors:  G Furness; M Trocola
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226
View more
  3 in total

Review 1.  Antimicrobial chemotherapy of chlamydial infection: where next?

Authors:  G L Ridgway
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

2.  Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.

Authors:  J A Robertson; J E Coppola; O R Heisler
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

3.  Activities of new quinoline derivatives against genital pathogens.

Authors:  J Aznar; M C Caballero; M C Lozano; C de Miguel; J C Palomares; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.